Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
06 10 2021
Historique:
received: 24 06 2021
accepted: 13 09 2021
entrez: 7 10 2021
pubmed: 8 10 2021
medline: 21 10 2021
Statut: epublish

Résumé

Several COVID-19 vaccines have shown good efficacy in clinical trials, but there remains uncertainty about the efficacy of vaccines against different variants. Here, we investigate the efficacy of ChAdOx1 nCoV-19 (AZD1222) against symptomatic COVID-19 in a post-hoc exploratory analysis of a Phase 3 randomised trial in Brazil (trial registration ISRCTN89951424). Nose and throat swabs were tested by PCR in symptomatic participants. Sequencing and genotyping of swabs were performed to determine the lineages of SARS-CoV-2 circulating during the study. Protection against any symptomatic COVID-19 caused by the Zeta (P.2) variant was assessed in 153 cases with vaccine efficacy (VE) of 69% (95% CI 55, 78). 49 cases of B.1.1.28 occurred and VE was 73% (46, 86). The Gamma (P.1) variant arose later in the trial and fewer cases (N = 18) were available for analysis. VE was 64% (-2, 87). ChAdOx1 nCoV-19 provided 95% protection (95% CI 61%, 99%) against hospitalisation due to COVID-19. In summary, we report that ChAdOx1 nCoV-19 protects against emerging variants in Brazil despite the presence of the spike protein mutation E484K.

Identifiants

pubmed: 34615860
doi: 10.1038/s41467-021-25982-w
pii: 10.1038/s41467-021-25982-w
pmc: PMC8494913
doi:

Substances chimiques

COVID-19 Vaccines 0
ChAdOx1 nCoV-19 B5S3K2V0G8

Types de publication

Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5861

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19055
Pays : United Kingdom

Investigateurs

David Buck (D)
Angie Green (A)
George MacIntyre-Cockett (G)
Paolo Piazza (P)
John A Todd (JA)
Amy Trebes (A)
Laura Thomson (L)
Lygia Accioly Tinoco (LA)
Karla Cristina Marques Afonso Ferreira (KCMA)
Cenusa Almeida (C)
Brian Angus (B)
Beatriz Arns (B)
Laiana Arruda (L)
Renato De Ávila Kfouri (R)
Lucas Henrique Azevedo da Silva (LHA)
Matheus José Barbosa Moreira (MJB)
Brenda Vasconcelos Barbosa Paiva (BVB)
Louise Bates (L)
Nancy Bellei (N)
Bruno Boettger (B)
Leandro Bonecker Lora (LB)
Nina Amanda Borges de Araújo (NAB)
Chrystiane do Nascimento Brito de Oliveira (CDNB)
Charlie Brown-O'Sullivan (C)
Daniel Calich Luz (DC)
Joao Renato Cardoso Mourão (JRC)
Caroline Scherer Carvalho (CS)
Paola Cicconi (P)
Ana Gibertoni Cruz (AG)
Debora Cunha (D)
Daniel Marinho Da Costa (DM)
Isabela Garrido Da Silva Gonzalez (IG)
Priscila de Arruda Trindade (P)
Bruno Solano de Freitas Souza (BS)
Sergio Carlos Assis De Jesus Junior (SCA)
Maria Isabel de Moraes Pinto (MI)
Karolyne Porto De Mores (KP)
Maristela Miyamoto de Nobrega (MM)
Milla Dias Sampaio (MD)
Janaína Keyla Dionísio Dos Santos (JKD)
Alexander D Douglas (AD)
Suzete Nascimento Farias da Guarda (SNF)
Mujtaba Ghulam Farooq (MG)
Shuo Feng (S)
Marcel Catão Ferreira Dos Santos (MCF)
Marília Miranda Franco (MM)
Marianne Garcia de Oliveira (MG)
Fernanda Garcia Spina (FG)
Tannyth Gomes Dos Santos (TG)
Alvaro Henrique Goyanna (AH)
Rosana Esteves Haddad (RE)
Adrian V S Hill (AVS)
Mimi M Hou (MM)
Bruna Junqueira (B)
Bruna Somavilla Kelling (BS)
Baktash Khozoee (B)
Renan Gustavo Kunst (RG)
Jonathan Kwok (J)
Meera Madhavan (M)
José Antônio Mainardi de Carvalho (JAM)
Olga Mazur (O)
Angela M Minassian (AM)
Leonardo Motta Ramos (LM)
Celia Hatsuko Myasaki (CH)
Helena Carolina Noal (HC)
Natália Nóbrega de Lima (NN)
Rabiullah Noristani (R)
Ana Luiza Perez (AL)
Daniel J Phillips (DJ)
Priscila Pinheiro (P)
Jéssica Morgana Gediel Pinheiro (JMG)
Marie Marcelle Prestes Camara (MMP)
Isabella Queiroz (I)
Alessandra Ramos Souza (AR)
Thais Regina Y Castro (TRY)
Hannah Robinson (H)
Marianna Rocha Jorge (MR)
Talita Rochetti (T)
Mariana Bernadi S Saba (MBS)
Natalia Zerbinatti Salvador (NZ)
Fernanda Caldeira Veloso Santos (FCV)
Mayara Fraga Santos Guerra (MFS)
Samiullah Seddiqi (S)
Roberta Senger (R)
Robert Shaw (R)
Airanuedida Silva Soares (AS)
Rinn Song (R)
Guilherme G Sorio (GG)
Ricardo Stein (R)
Arabella V S Stuart (AVS)
Tais Tasqueto Tassinari (TT)
Cheryl Turner (C)
Tarsila Vieceli (T)
Taiane A Vieira (TA)
João Gabriel Villar Cavalcanti (JGV)
Marion E E Watson (MEE)
Andy Yao (A)
Rafael Zimmer (R)

Informations de copyright

© 2021. The Author(s).

Références

Cell. 2021 May 27;184(11):2939-2954.e9
pubmed: 33852911
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
N Engl J Med. 2021 Apr 15;384(15):1412-1423
pubmed: 33626250
Virus Evol. 2021 Dec 15;7(2):veab091
pubmed: 35039782
Nat Commun. 2021 Oct 7;12(1):5868
pubmed: 34620866
Virus Evol. 2018 May 18;4(1):vey007
pubmed: 29876136
Nat Med. 2021 Jul;27(7):1230-1238
pubmed: 34035535
N Engl J Med. 2021 May 20;384(20):1899-1909
pubmed: 33951374
Science. 2021 Apr 16;372(6539):
pubmed: 33688063
Lancet. 2021 Mar 6;397(10277):881-891
pubmed: 33617777
BMJ. 2021 May 13;373:n1088
pubmed: 33985964
Lancet. 2021 Apr 10;397(10282):1351-1362
pubmed: 33798499
Nature. 2021 May;593(7857):136-141
pubmed: 33706364
Lancet. 2021 Jan 9;397(10269):99-111
pubmed: 33306989
N Engl J Med. 2021 Jun 10;384(23):2187-2201
pubmed: 33882225
Lancet. 2020 Aug 15;396(10249):467-478
pubmed: 32702298
Lancet Microbe. 2021 Jul;2(7):e283-e284
pubmed: 33846703
N Engl J Med. 2021 Jul 8;385(2):187-189
pubmed: 33951357
Nat Med. 2021 Aug;27(8):1379-1384
pubmed: 34127854
Lancet. 2021 May 8;397(10286):1725-1735
pubmed: 33901423
J Virol. 2021 Mar 1;95(10):
pubmed: 33649194
Lancet. 2021 Apr 17;397(10283):1459-1469
pubmed: 33844963
Cell Host Microbe. 2021 May 12;29(5):747-751.e4
pubmed: 33887205
Science. 2021 May 21;372(6544):815-821
pubmed: 33853970
Lancet. 2021 Feb 6;397(10273):452-455
pubmed: 33515491
Cell. 2021 Apr 29;184(9):2348-2361.e6
pubmed: 33730597
Emerg Infect Dis. 2021 May;27(5):1522-1524
pubmed: 33605869
Science. 2021 Jan 15;371(6526):288-292
pubmed: 33293339
Lancet Infect Dis. 2020 Aug;20(8):e192-e197
pubmed: 32539990
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Science. 2021 Jul 16;373(6552):
pubmed: 34083451
N Engl J Med. 2021 May 20;384(20):1885-1898
pubmed: 33725432
Nature. 2021 May;593(7857):130-135
pubmed: 33684923

Auteurs

Sue Ann Costa Clemens (SAC)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Institute of Global Health, University of Siena, Siena, Italy.

Pedro M Folegatti (PM)

The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Katherine R W Emary (KRW)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.

Lily Yin Weckx (LY)

Department of Pediatrics, Universidade Federal de São Paulo, São Paulo, Brazil.

Jeremy Ratcliff (J)

Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.

Sagida Bibi (S)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.

Ana Verena De Almeida Mendes (AV)

Escola Bahiana de Medicina e Saúde Pública, Brazil and ID'OR, Salvador, Brazil.
Hospital São Rafael, Salvador, Brazil.

Eveline Pipolo Milan (EP)

Universidade Federal do Rio Grande do Norte - UFRN, Natal, Brazil.

Ana Pittella (A)

Hospital Quinta D'Or, Rio de Janeiro, Brazil.
Instituto D'Or de Pesquisa e Ensino (IDOR), Rio de Janeiro, Brazil.
Universidade Unigranrio, Rio de Janeiro, Brazil.

Alexandre V Schwarzbold (AV)

Clinical Research Unit, Department of Clinical Medicine, Universidade Federal de Santa Maria, Santa Maria, Brazil.

Eduardo Sprinz (E)

Infectious Diseases Service, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil.
Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

Parvinder K Aley (PK)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.

David Bonsall (D)

Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Christophe Fraser (C)

Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Michelle Fuskova (M)

The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Sarah C Gilbert (SC)

The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Daniel Jenkin (D)

The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Sarah Kelly (S)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.

Simon Kerridge (S)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.

Teresa Lambe (T)

The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Natalie G Marchevsky (NG)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.

Yama F Mujadidi (YF)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.

Emma Plested (E)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.

Maheshi N Ramasamy (MN)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Peter Simmonds (P)

Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.

Tanya Golubchik (T)

Oxford Viral Sequencing Group, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.

Merryn Voysey (M)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. merryn.voysey@paediatrics.ox.ac.uk.

Andrew J Pollard (AJ)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Andrew.pollard@paediatrics.ox.ac.uk.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH